RCM
ABBV icon

Raleigh Capital Management’s AbbVie ABBV Stock Holding History

Raleigh Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Buy
18,091
+2,730
+18% +$587K 1.45% 11
2026
Q1 		$3.34M Buy
15,361
+176
+1% +$39K 1.15% 16
2025
Q4 		$3.47M Sell
15,185
-1,659
-10% -$378K 1.26% 12
2025
Q3 		$3.9M Buy
16,844
+193
+1% +$39.3K 1.48% 8
2025
Q2 		$3.09M Buy
16,651
+1,446
+10% +$269K 1.3% 10
2025
Q1 		$3.19M Buy
15,205
+545
+4% +$106K 1.44% 9
2024
Q4 		$2.61M Buy
14,660
+2,608
+22% +$479K 1% 16
2024
Q3 		$2.38M Sell
12,052
-162
-1% -$30.2K 0.92% 18
2024
Q2 		$2.09M Sell
12,214
-769
-6% -$127K 0.89% 22
2024
Q1 		$2.36M Sell
12,983
-4,239
-25% -$731K 1.02% 16
2023
Q4 		$2.67M Buy
17,222
+647
+4% +$94.3K 1.24% 15
2023
Q3 		$2.47M Buy
16,575
+143
+0.9% +$21K 1.26% 13
2023
Q2 		$2.21M Sell
16,432
-2,658
-14% -$390K 1.1% 19
2023
Q1 		$3.04M Buy
19,090
+587
+3% +$89.7K 1.51% 8
2022
Q4 		$2.99M Buy
18,503
+821
+5% +$126K 1.56% 10
2022
Q3 		$2.37M Buy
17,682
+1,379
+8% +$198K 1.39% 11
2022
Q2 		$2.5M Sell
16,303
-1,726
-10% -$264K 1.42% 11
2022
Q1 		$2.92M Buy
18,029
+1,872
+12% +$272K 1.58% 9
2021
Q4 		$2.19M Buy
+16,157
New +$1.91M 2.24% 9

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raleigh Capital Management's ABBV Position: Q2 2026 in Review

Raleigh Capital Management increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $587K and bringing the position to 18,091 shares worth $4.55M. The position accounts for 1.45% of the portfolio, ranked #11.

Raleigh Capital Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Raleigh Capital Management held 18,091 shares of AbbVie worth $4.55M as of Q2 2026.
  • Raleigh Capital Management bought 2,730 AbbVie shares in Q2 2026, an estimated $587K.
  • AbbVie made up 1.45% of Raleigh Capital Management's portfolio in Q2 2026, its #11 holding.
  • Raleigh Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.